Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Healthcare
Biotechnology
10.80 $
+6.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Artiva Biotherapeutics, Inc. Common Stock (ARTV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -77 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -14 | -15 | -51 | -47 | -55 | -77 | |
| 0.1 | 0.2 | 1.2 | 2.3 | 2.4 | 2.6 | |
| 0.3 | 4.3 | 6.6 | 7.1 | 7.0 | 6.8 | |
| 4.4 | 33 | -3.9 | -28 | -0.3 | -0.4 | |
| 0.3 | 1.7 | 6.3 | 3.3 | 0.6 | 2.6 | |
| -0.3 | -1.7 | -6.3 | -26 | -120 | 63 | |
| – | – | 0.0 | 0.0 | -4.2 | 0.0 | |
| – | 0.0 | – | 0.0 | -0.1 | -0.1 | |
| 37 | 153 | -1.3 | 24 | 162 | 0.0 | |
| 24 | 136 | -58 | -49 | -13 | -13 | |
| -14 | -17 | -57 | -51 | -56 | -79 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.